Joseph Stauffer

Joseph W.
Stauffer currently works at Biofuse Medical Technologies, Inc., as Director from 2022, American Medical Association, as Member, American Society of Anesthesiologists, as Member, The Johns Hopkins Medical & Surgical Association, as Member, College on Problems of Drug Dependence, Inc., as Member, and Initiative On Methods, Measurement & Pain Assessment In Clinic, as Member.
Dr. Stauffer also formerly worked at Abbott Laboratories, as Global Medical Director in 2004, Cassava Sciences, Inc., as Global Medical Director in 2004, TrialScope, Inc., as Director, Zoetis Products LLC, as Chief Medical Officer & Senior Vice President in 2009, DURECT Corp., as Chief Medical Officer & EVP-Corporate Strategy from 2009 to 2011, Alpharma Specialty Pharma LLC, as Chief Medical Officer from 2004 to 2009, Signature Therapeutics, Inc., as Chief Medical Officer & VP-Corporate Strategy, CARA Therapeutics, Inc., as Chief Medical Officer from 2014 to 2018, Ikaria, Inc., as Chief Medical Officer from 2012 to 2014, Antibe Therapeutics, Inc., as Vice President-Clinical Development, and The Johns Hopkins University School of Medicine, as Assistant Professor.
Dr. Stauffer received his Masters Business Admin degree from New York University, Masters Business Admin degree from London School of Economics & Political Science, Masters Business Admin degree from École des Hautes Études Commerciales de Paris, and undergraduate degree and graduate degree from Philadelphia College of Osteopathic Medicine.